Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants
Clinical trial NCT03606746 · WITHDRAWN
Trial details
- NCT number
- NCT03606746
- Sponsor
- Medeor Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.